Assembly Biosciences (ASMB) Competitor Comparison
We are evaluating the key criteria listed to compare Assembly Biosciences (ASMB) against its competitors in the Biotechnology industry.
Market Capitalization
281 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
170 / 337Free Cashflow
197 / 352Quick Ratio
146 / 357Earnings per Share
332 / 359Dividend yield
0 / 6Total Cash
262 / 358Performance 3 years
153 / 368Performance 5 years
297 / 368Performance 10 years
201 / 368Linearity 3 years
89 / 368Linearity 5 years
300 / 368Linearity 10 years
73 / 367Total Rank
181 / 368Dividend Rank
364 / 368Valuation Rank
138 / 368Piotroski Rank
136 / 368Muliplier Rank
67 / 368Market Capitalization - ASMB ranking 281 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.